VERAMED LIMITED
Get an alert when VERAMED LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-05-05 (in 1y)
Last made up 2026-04-21
Watchouts
None on the register
Cash
£5M
+19.8% highest in 4 filed years
Net assets
£18M
+22.7% highest in 4 filed years
Employees
198
+9.4% highest in 4 filed years
Profit before tax
£4M
+7.6% vs 2023
Net assets
4-year trend · vs Technology median
Accounts
4-year trend · latest reflected 2024-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Turnover | — | — | £33,974,442 | £36,628,936 | |
| Operating profit | — | — | £4,009,404 | £4,028,418 | |
| Profit before tax | — | — | £4,103,095 | £4,413,301 | |
| Net profit | — | — | £3,738,653 | £3,308,558 | |
| Cash | £966,513 | £2,503,974 | £4,521,705 | £5,418,440 | |
| Total assets less current liabilities | — | — | — | — | |
| Net assets | £3,119,613 | £5,340,488 | £14,548,237 | £17,856,795 | |
| Equity | £3,119,613 | £5,340,488 | £14,548,237 | £17,856,795 | |
| Average employees | 50 | 70 | 181 | 198 | |
| Wages | — | — | £9,690,445 | £11,515,734 | |
| Directors' remuneration | — | — | £921,462 | £1,232,875 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+7.8%
£33,974,442 £36,628,936
-
Cash
+19.8%
£4,521,705 £5,418,440
highest in 4 filed years
-
Net assets
+22.7%
£14,548,237 £17,856,795
highest in 4 filed years
-
Employees
+9.4%
181 198
highest in 4 filed years
-
Operating profit
+0.5%
£4,009,404 £4,028,418
-
Profit before tax
+7.6%
£4,103,095 £4,413,301
-
Wages
+18.8%
£9,690,445 £11,515,734
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-12-31 | 2020-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Operating margin | — | — | 11.8% | 11.0% | |
| Net margin | — | — | 11.0% | 9.0% | |
| Current ratio | — | — | 4.49x | 1.77x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- VERAMED LIMITED 2011-11-15 → present
- IDYLLIC LIMITED 2010-03-19 → 2011-11-15
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Crowe U.K. LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors consider the going concern basis to be appropriate having paid due regard to the company's projected results during the twelve months from the date the financial statements are approved and the anticipated cash flows, availability of loan facilities and mitigating actions that can be taken during that period. Furthermore, the company has received confirmation from Matrix 2021 Holdings Limited that it will support the company for a period of at least twelve months from the date of approval of these financial statements, including the non-recall of amounts owed to group undertakings.”
Group structure
- VERAMED LIMITED · parent
- Veramed Ukraine LLC 100%
- Veramed Inc. 100%
- Veramed GmbH 100%
- Veramed Data Services Private Limited 100%
- Veramed Arrow US Inc. 100%
- Clinical Data Trial Services, LLC 100%
- Veramed Canada Ltd. 100%
- Veramed Shannon Inc. 100%
- BioPier, LLC 100%
Significant events
- “The company has operations in Ukraine.”
- “The company's future challenges include the successful integration of acquired companies, continued commercial and operational expansion in the US and India, and maintaining a strong employee value proposition globally as the company continues to grow.”
- “There have been no significant events affecting the company since the year end.”
- “No significant post balance sheet events affecting the company have been identified.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHHOA-WILSON, Charles Guy | Director | 2020-03-02 | Nov 1978 | British |
| HUTCHINSON, Katherine | Director | 2022-06-20 | Dec 1964 | British |
| JONES, Emma Louise, Dr. | Director | 2016-09-01 | Sep 1980 | British |
| JONES, Matthew Peter Andrew | Director | 2010-03-19 | Jun 1977 | British |
| MCGUIRE, Stuart | Director | 2020-03-02 | Jun 1976 | British |
| RYALLS, Daniel Lee | Director | 2024-07-01 | Jul 1974 | British |
| SEYMOUR, Thomas Michael | Director | 2022-12-20 | Feb 1983 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mrs Emma Louise Jones | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2021-03-02 | Ceased 2021-10-26 |
| Matrix 2021 Bidco Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-10-26 | Active |
| Mr Matthew Jones | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2016-04-06 | Ceased 2021-10-26 |
Filing timeline
Last 20 of 70 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-03 | AA | accounts | Accounts with accounts type full | |
| 2025-05-09 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-04-28 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-07-30 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-16 | CH01 | officers | Change person director company with change date | |
| 2024-07-12 | CH01 | officers | Change person director company with change date | |
| 2024-07-08 | AA | accounts | Accounts with accounts type full | |
| 2024-05-03 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-04-30 | SH01 | capital | Capital allotment shares | |
| 2024-03-12 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-02-21 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-12-14 | SH01 | capital | Capital allotment shares | |
| 2023-10-12 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-06-13 | AA | accounts | Accounts with accounts type full | |
| 2023-04-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-12-20 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-26 | AA | accounts | Accounts with accounts type full | |
| 2022-06-30 | AP01 | officers | Appoint person director company with name date | |
| 2022-04-21 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.